Search Results By Date:
Showing 1 - 15 of 611 results
  • Trentham-Dietz A, Corley DA, Del Vecchio NJ, Greenlee RT, Haas JS, Hubbard RA,...Tiro JA. Data gaps and opportunities for modeling cancer health equity. J Natl Cancer Inst Monogr. 2023 November 8;2023(62):246-254. doi: 10.1093/jncimonographs/lgad025.
    PubMed ID: 37947335
  • Neslund-Dudas C, Tang A, Alleman E, Zarins KR, Li P, Simoff MJ,...Ritzwoller DP [including Greenlee RT.] Uptake of Lung Cancer Screening CT After a Provider Order for Screening in the PROSPR-Lung Consortium. [published online ahead of print 2023 October 2]. J Gen Intern Med. PMCID: 1756972.
    PubMed ID: 37783984
  • Unger JM, Stires H, Levit LA, Stewart M, McKelvey BA, Canin B,...Schenkel C [including Onitilo AA.] Sponsor Perspectives on the Impact of the COVID-19 Pandemic on Interventional Cancer Clinical Trial Protocols and Data Quality. JCO Oncol Pract. 2023 October; 19(10):907-916. doi: 10.1200/OP.23.00185.
    PubMed ID: 37643386
  • Shour AR, Jones GL, Anguzu R, Doi SA, Onitilo AA. Development of an evidence-based model for predicting patient, provider, and appointment factors that influence no-shows in a rural healthcare system. BMC Health Serv Res. 2023 September 14; 23(1):989. doi: 10.1186/s12913-023-09969-5. PMCID: PMC10503036.
    PubMed ID: 37710258
  • Srinivasulu Yerukala Sathipati, Nikhila Aimalla, Ming-Ju Tsai, Tonia Carter, Sohyun Jeong, Zhi Wen,...Shinn-Ying Ho [including Sanjay K Shukla, Rohit Sharma.] Prognostic microRNA signature for estimating survival in patients with hepatocellular carcinoma. [published online ahead of print 2023 September 13]. Carcinogenesis. doi:
  • Marlow EC, Ducore JM, Kwan ML, Bowles EJA, Greenlee RT, Pole JD,...Miglioretti DL. Medical imaging utilization and associated radiation exposure in children with down syndrome. PLoS One. 2023 September 6; 18(9):e0289957. doi: 10.1371/journal.pone.0289957. PMCID: PMC10482278.
    PubMed ID: 37672503
  • Burnett-Hartman AN, Powers JD, Hixon BP, Carroll NM, Frankland TB, Honda SA,...Ritzwoller DP [including Greenlee RT.] Development of an Electronic Health Record-Based Algorithm for Predicting Lung Cancer Screening Eligibility in the Population-Based Research to Optimize the Screening Process Lung Research Consortium. JCO Clin Cancer Inform. 2023 September; 7 :e2300063.
    PubMed ID: 37910824
  • Joseph A, Akinsete A, Adeneye S, Balogun O, Awofeso O, Oladipo A,...Onitilo AA [including Puthoff D, Shour A.] Feasibility and Safety of Implementing Volumetric Arc Therapy (VMAT) for Pediatric Craniospinal Irradiation in a Low-Middle-Income Region: The Nigerian Experience. Advances in Radiation Oncology. 2023 July 28; :101325. doi: 10.1016/j.adro.2023.101325.
  • Burnett-Hartman AN, Carroll NM, Croswell JM, Greenlee RT, Honda SA, Neslund-Dudas CM,...Ritzwoller DP. Percentage Up to Date With Chest Computed Tomography Among Those Eligible for Lung Cancer Screening. Am J Prev Med. 2023 July; 65(1):126-130. doi: 10.1016/j.amepre.2023.01.002. PMCID: PMC10293017.
    PubMed ID: 36707314
  • Bulen BJ, Khazanov NA, Hovelson DH, Lamb LE, Matrana M, Burkard ME,...Tomlins SA [including Onitilo AA.] Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit. Cancer Res Commun. 2023 July; 3(7):1335-1349. doi: 10.1158/2767-9764.CRC-23-0036. PMCID: PMC10367935.
    PubMed ID: 37497337
  • Carroll NM, Eisenstein J, Burnett-Hartman AN, Greenlee RT, Honda SA, Neslund-Dudas CM,...Ritzwoller DP. Uptake of novel systemic therapy: Real world patterns among adults with advanced non-small cell lung cancer. [published online ahead of print 2023 June 14]. Cancer Treat Res Commun. 36 :100730.
    PubMed ID: 37352588
  • Navari RM, Le-Rademacher J, Smieliauskas F, Ruddy KJ, James Saphner T, Liu H,...Loprinzi CL [including Onitilo AA.] Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602). [published online ahead of print 2023 June 7]. Oncologist. doi: 10.1093/oncolo/oyad140.
    PubMed ID: 37284847
  • Shour A, onitilo AA, Anguzu R. The impact of minority health social vulnerability on population-based cancer incidence. [published online ahead of print 2023 May 25]. JOURNAL OF CLINICAL ONCOLOGY. 41(16):e22501. doi: 10.1200/JCO.2023.41.16\_suppl.e22501.
  • Carroll NM, Burnett-Hartman AN, Rendle KA, Neslund-Dudas CM, Greenlee RT, Honda SA,...Ritzwoller DP. Smoking status and the association between patient-level factors and survival among lung cancer patients. [published online ahead of print 2023 May 25]. J Natl Cancer Inst.
    PubMed ID: 37228018
  • Panich J, Irwin C, Bissonette A, Elkhidir S, Lodhi F, Folz C,...Kattamanchi S [including Abboud Leon C.] Cohort study on immune checkpoint inhibitor-associated acute kidney injury: Incidence, risk factors, and management strategies. [published online ahead of print 2023 April 26]. J Oncol Pharm Pract. :10781552231171078. doi: 10.1177/10781552231171078.
    PubMed ID: 37125423